{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:15:19Z","timestamp":1786990519725,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ijcard.2015.08.088","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T12:30:22Z","timestamp":1439382622000},"page":"20-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Uric acid lowering therapy in cardiovascular diseases"],"prefix":"10.1016","volume":"213","author":[{"given":"Maurizio","family":"Volterrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Iellamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sposato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.08.088_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11906-013-0344-5","article-title":"Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?","volume":"15","author":"Soltani","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/heartjnl-2012-302535","article-title":"The role of uric acid in the pathogenesis of human cardiovascular disease","volume":"99","author":"Kanbay","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2459\/JCM.0b013e3283595adc","article-title":"Hyperuricaemia: more than just a cause of gout?","volume":"14","author":"Katsiki","year":"2013","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0020","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archinte.168.10.1104","article-title":"Long-term cardiovascular mortality among middle-aged men with gout","volume":"168","author":"Krishnan","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0025","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"Choi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0030","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/qjmed\/hct083","article-title":"Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality","volume":"106","author":"Stack","year":"2013","journal-title":"Q. J. Med."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0035","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.HYP.36.6.1072","article-title":"Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA Study","volume":"36","author":"Verdecchia","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0040","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.STR.0000221716.55088.d4","article-title":"Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam Study","volume":"37","author":"Bos","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0045","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.amjcard.2004.06.032","article-title":"Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk","volume":"94","author":"Mercuro","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.HYP.0000150783.79172.bb","article-title":"Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study","volume":"45","author":"Alper","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0055","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/01.HYP.0000249768.26560.66","article-title":"Serum uric acid predicts incident hypertension in a biethnic cohort: the Atherosclerosis Risk in Communities study","volume":"48","author":"Mellen","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0060","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.HYP.0000248752.08807.4c","article-title":"Uric acid and the development of hypertension: the Normative Aging Study","volume":"48","author":"Perlstein","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.HYP.0000254480.64564.b6","article-title":"Hyperuricemia and incidence of hypertension among men without metabolic syndrome","volume":"49","author":"Krishnan","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1681\/ASN.2006080865","article-title":"Plasma uric acid level and risk for incident hypertension among men","volume":"18","author":"Forman","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/01.HYP.0000150784.92944.9a","article-title":"Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence","volume":"45","author":"Sundstrom","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta-analysis","volume":"63","author":"Grayson","year":"2010","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0085","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0090","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0095","doi-asserted-by":"crossref","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","article-title":"Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism","volume":"282","author":"Mazzali","year":"2002","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0100","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"Khosla","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0105","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11255-007-9253-3","article-title":"Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions","volume":"39","author":"Kanbay","year":"2007","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0110","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0115","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/HYPERTENSIONAHA.112.196980","article-title":"Uric acid reduction rectifies prehypertension in obese adolescents","volume":"60","author":"Soletsky","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2011.04.004","article-title":"Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production","volume":"51","author":"Malik","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0125","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1253\/circj.CJ-13-0082","article-title":"Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients (NU-FLASH trial)","volume":"77","author":"Sezai","year":"2013","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0130","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1592\/phco.30.6.594","article-title":"Urate-lowering therapy for gout: focus on febuxostat","volume":"30","author":"Love","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0135","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1371\/journal.pmed.0020076","article-title":"Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis","volume":"2","author":"Wheeler","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0140","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/art.22014","article-title":"Gout and the risk of acute myocardial infarction","volume":"54","author":"Krishnan","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0145","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/ard.2009.122770","article-title":"Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study","volume":"69","author":"De Vera","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0150","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.amjmed.2005.03.043","article-title":"Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?","volume":"118","author":"Baker","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","article-title":"Hyperuricemia and coronary heart disease: a systematic review and meta-analysis","volume":"62","author":"Kim","year":"2010","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0160","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1053\/euhj.1998.1188","article-title":"UA in chronic HF: a marker of chronic inflammation","volume":"19","author":"Leyva","year":"1998","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0165","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1183\/09031936.99.13368299","article-title":"Hyperuricaemia in patients with right or left HF","volume":"13","author":"Hoeper","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0170","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/oxfordjournals.eurheartj.a015352","article-title":"Serum UA as an index of impaired oxidative metabolism in chronic HF","volume":"18","author":"Leyva","year":"1997","journal-title":"Eur. Heart"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0175","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/eci.12273","article-title":"Uricaemia and ejection fraction in elderly heart failure outpatients","volume":"44","author":"Borghi","year":"2014","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0180","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11739-013-1016-9","article-title":"Serum uric acid is inversely associated to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study","volume":"9","author":"Cicero","year":"2014","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0185","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging","volume":"107","author":"Anker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0190","doi-asserted-by":"crossref","first-page":"e000282","DOI":"10.1136\/bmjopen-2011-000282","article-title":"Gout and the risk for incident heart failure and systolic dysfunction","volume":"2","author":"Krishnan","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1755-5922.2011.00277.x","article-title":"Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis","volume":"30","author":"Higgins","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0200","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/01.CIR.0000017502.58595.ED","article-title":"Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies","volume":"105","author":"Doehner","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0205","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/hc4501.098928","article-title":"Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy","volume":"104","author":"Cappola","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","article-title":"Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo controlled crossover preliminary study","volume":"3","author":"Ogino","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0215","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cardfail.2008.06.006","article-title":"Xanthine oxidase inhibition with febuxostat attenuates systolic overload-induced left ventricular hypertrophy and dysfunction in mice","volume":"14","author":"Xu","year":"2008","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0220","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cjca.2012.04.005","article-title":"Effects of allopurinol on coronary microvascular and left ventricular function in patients with idiopathic dilated cardiomyopathy","volume":"28","author":"Erdogan","year":"2012","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0225","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","article-title":"Impact of oxypurinol in patients with symptomatic HF. Results of the OPT-CHF study","volume":"51","author":"Hare","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0230","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/CRD.0b013e318229a908","article-title":"Allopurinol as a cardiovascular drug","volume":"19","author":"Kelkar","year":"2011","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0235","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/archinternmed.2010.198","article-title":"Gout, allopurinol use, and heart failure outcomes","volume":"170","author":"Thanassoulis","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0240","first-page":"51","article-title":"Impact of allopurinol on risk of myocardial infarction","volume":"103","author":"Grimaldi-Bensouda","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0245","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.yjmcc.2005.04.008","article-title":"XO inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced HF","volume":"39","author":"Amado","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0250","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/01.RES.0000200181.59551.71","article-title":"Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy","volume":"98","author":"Minhas","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0255","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1113\/jphysiol.2003.055913","article-title":"Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications","volume":"555","author":"Berry","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.ijcard.2015.08.088_bb0260","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.CIR.0000022140.61460.1D","article-title":"Allopurinol improves endothelial dysfunction in chronic HF","volume":"106","author":"Farquharson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.088_bb0265","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","article-title":"High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering UA","volume":"114","author":"George","year":"2006","journal-title":"Circulation"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315303181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315303181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T10:08:41Z","timestamp":1718014121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315303181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":53,"alternative-id":["S0167527315303181"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.088","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uric acid lowering therapy in cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}